Literature DB >> 12475811

Overview of pulmonary fibrosis.

Francis H Y Green1.   

Abstract

Pulmonary fibrosis is a component of over 200 interstitial lung diseases. Some have known etiologies, however, for many diseases, the etiology remains unknown or obscure. This brief review examines the prevalence and classification of these diseases, the approach to be taken for the investigation of a patient suspected of having pulmonary fibrosis, the indications for the performance of lung biopsy, and current thoughts concerning the pathogenesis of the idiopathic forms of fibrotic lung disease. A brief review of established and emerging therapeutic strategies is included.

Entities:  

Mesh:

Year:  2002        PMID: 12475811     DOI: 10.1378/chest.122.6_suppl.334s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  28 in total

Review 1.  Disorders of lung matrix remodeling.

Authors:  Harold A Chapman
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

2.  Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia.

Authors:  E S Choi; E M Pierce; C Jakubzick; K J Carpenter; S L Kunkel; H Evanoff; F J Martinez; K R Flaherty; B B Moore; G B Toews; T V Colby; E A Kazerooni; B H Gross; W D Travis; C M Hogaboam
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

3.  Lower expression of platelet derived growth factor is associated with better overall survival rate of patients with idiopathic nonspecific interstitial pneumonia.

Authors:  Xuyou Zhu; Xia Fang; Wei Chen; Fei Han; Ziling Huang; Benfang Luo; Pan Gu; Long Zhang; Weizhe Qiu; Yu Zeng; Weiwei Rui; Xianghua Yi
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 4.  Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts.

Authors:  M Hetzel; M Bachem; D Anders; G Trischler; M Faehling
Journal:  Lung       Date:  2005 Jul-Aug       Impact factor: 2.584

5.  Gene expression profiling of familial and sporadic interstitial pneumonia.

Authors:  Ivana V Yang; Lauranell H Burch; Mark P Steele; Jordan D Savov; John W Hollingsworth; Erin McElvania-Tekippe; Katherine G Berman; Marcy C Speer; Thomas A Sporn; Kevin K Brown; Marvin I Schwarz; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2006-09-22       Impact factor: 21.405

6.  The preventive effect of atorvastatin on paraquat-induced pulmonary fibrosis in the rats.

Authors:  Mohammad Javad Khodayar; Milad Kiani; Ali Asghar Hemmati; Anahita Rezaie; Mohammad Rahim Zerafatfard; Mohammad Reza Rashidi Nooshabadi; Mehdi Goudarzi
Journal:  Adv Pharm Bull       Date:  2014-08-10

7.  Expression of fibroblast growth factor 9 in normal human lung and idiopathic pulmonary fibrosis.

Authors:  Emily Coffey; Donna R Newman; Philip L Sannes
Journal:  J Histochem Cytochem       Date:  2013-06-24       Impact factor: 2.479

8.  MEK inhibition suppresses the development of lung fibrosis in the bleomycin model.

Authors:  Maria Galuppo; Emanuela Esposito; Emanuela Mazzon; Rosanna Di Paola; Irene Paterniti; Daniela Impellizzeri; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

9.  Involvement of pulmonary endothelial cell injury in the pathogenesis of pulmonary fibrosis: clinical assessment by 123I-MIBG lung scintigraphy.

Authors:  Noriaki Takabatake; Tsuyoshi Arao; Makoto Sata; Shuichi Abe; Sumito Inoue; Yoko Shibata; Yasuchika Takeishi; Isao Kubota
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-23       Impact factor: 9.236

10.  S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways.

Authors:  X Xu; H Chen; X Zhu; Y Ma; Q Liu; Y Xue; H Chu; W Wu; J Wang; H Zou
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.